Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Altmann

Showing results (361-370 of 383) with videos related to

Pageof 39
Sort By:
Gut|July 28, 2022
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemicNicholas A Kennedy, Malik Janjua, Neil Chanchlani, et al.
Gut|April 12, 2019
Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trialEdward S Chambers, Claire S Byrne, Douglas J Morrison, et al.
Science (New York, N.Y.)|May 1, 2021
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine doseCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.
The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.
Ebiomedicine|October 1, 2022
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infectionGabriella Captur, James C Moon, Constantin-Cristian Topriceanu, et al.
The Journal of Clinical Investigation|September 15, 2022
Loss of cardiomyocyte CYB5R3 impairs redox equilibrium and causes sudden cardiac deathNolan T Carew, Heidi M Schmidt, Shuai Yuan, et al.
Ebiomedicine|March 4, 2021
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infectionCharlotte Manisty, Thomas Alexander Treibel, Melanie Jensen, et al.
Science (New York, N.Y.)|December 2, 2021
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variantsCatherine J Reynolds, Joseph M Gibbons, Corinna Pade, et al.
Elife|December 17, 2020
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumoniaMichaela Gregorova, Daniel Morse, Tarcisio Brignoli, et al.
Immunology|February 14, 2022
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19Stuart Astbury, Catherine J Reynolds, David K Butler, et al.
Pageof 39

Showing results (361-370 of 383) with videos related to

Sort By:
Pageof 39
Gut|July 28, 2022
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemicNicholas A Kennedy, Malik Janjua, Neil Chanchlani, et al.
Gut|April 12, 2019
Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trialEdward S Chambers, Claire S Byrne, Douglas J Morrison, et al.
Science (New York, N.Y.)|May 1, 2021
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine doseCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.
The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.
Ebiomedicine|October 1, 2022
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infectionGabriella Captur, James C Moon, Constantin-Cristian Topriceanu, et al.
The Journal of Clinical Investigation|September 15, 2022
Loss of cardiomyocyte CYB5R3 impairs redox equilibrium and causes sudden cardiac deathNolan T Carew, Heidi M Schmidt, Shuai Yuan, et al.
Ebiomedicine|March 4, 2021
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infectionCharlotte Manisty, Thomas Alexander Treibel, Melanie Jensen, et al.
Science (New York, N.Y.)|December 2, 2021
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variantsCatherine J Reynolds, Joseph M Gibbons, Corinna Pade, et al.
Elife|December 17, 2020
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumoniaMichaela Gregorova, Daniel Morse, Tarcisio Brignoli, et al.
Immunology|February 14, 2022
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19Stuart Astbury, Catherine J Reynolds, David K Butler, et al.
Pageof 39